drugset / Trial / NCT04431687

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

NCT04431687

Phase 1 Completed 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D759 and D150

Timeline

Start
2020-06-15
Primary completion
2020-07-24
Completion
2020-10-26

Drugs

EvaluationDrugModalityDoseRoute
Subject D150 Unknown Oral
Subject D759 Unknown Oral
Subject Lobeglitazone Small molecule Oral